These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27095332)

  • 1. Sleep state misperception in schizophrenia: Are negative symptoms at work?
    Bian Y; Wang ZX; Han XL; Chen L; Zhu Y; Wu CJ
    Compr Psychiatry; 2016 May; 67():33-8. PubMed ID: 27095332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep misperception in persons with epilepsy.
    Ng MC; Bianchi MT
    Epilepsy Behav; 2014 Jul; 36():9-11. PubMed ID: 24835898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Delta/Beta ratio index as the sleep state-independent electrophysiological signature of sleep state misperception in Insomnia disorder: A focus on the sleep onset and the whole night.
    Fasiello E; Gorgoni M; Galbiati A; Sforza M; Berra F; Scarpelli S; Alfonsi V; Annarumma L; Casoni F; Zucconi M; Castronovo V; Ferini-Strambi L; De Gennaro L
    Neuroimage; 2024 Sep; 298():120782. PubMed ID: 39128660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chlorpromazine on sleep quality, clinical and emotional measures among patients with schizophrenia.
    Meng Q; Li R; Hou F; Zhang Q
    Clin Neurol Neurosurg; 2018 Feb; 165():134-138. PubMed ID: 29421173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of sleep EEG abnormalities in chronic schizophrenia.
    Yang C; Winkelman JW
    Schizophr Res; 2006 Feb; 82(2-3):251-60. PubMed ID: 16377158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The subjective-objective mismatch in sleep perception among those with insomnia and sleep apnea.
    Bianchi MT; Williams KL; McKinney S; Ellenbogen JM
    J Sleep Res; 2013 Oct; 22(5):557-68. PubMed ID: 23521019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep-wake misperception. A comprehensive analysis of a large sleep lab cohort.
    Valko PO; Hunziker S; Graf K; Werth E; Baumann CR
    Sleep Med; 2021 Dec; 88():96-103. PubMed ID: 34742039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between polysomnography and subjective sleep and its dependence on age - poor sleep may become good sleep.
    Åkerstedt T; Schwarz J; Gruber G; Lindberg E; Theorell-Haglöw J
    J Sleep Res; 2016 Oct; 25(5):565-570. PubMed ID: 27122391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia.
    Kim JH; Ann JH; Kim MJ
    Compr Psychiatry; 2010; 51(2):165-70. PubMed ID: 20152297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term study of the sleep of insomnia patients with sleep state misperception and other insomnia patients.
    Salin-Pascual RJ; Roehrs TA; Merlotti LA; Zorick F; Roth T
    Am J Psychiatry; 1992 Jul; 149(7):904-8. PubMed ID: 1609869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive sleep state misperception - a new concept of sleep misperception.
    Trajanovic NN; Radivojevic V; Kaushansky Y; Shapiro CM
    Sleep Med; 2007 Mar; 8(2):111-8. PubMed ID: 17275407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms.
    Müller MJ; Rossbach W; Mann K; Röschke J; Müller-Siecheneder F; Blümler M; Wetzel H; Russ H; Dittmann RW; Benkert O
    Pharmacopsychiatry; 2004 Jul; 37(4):157-62. PubMed ID: 15467971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring the error in sleep estimation in normal subjects and in patients with insomnia.
    Manconi M; Ferri R; Sagrada C; Punjabi NM; Tettamanzi E; Zucconi M; Oldani A; Castronovo V; Ferini-Strambi L
    J Sleep Res; 2010 Sep; 19(3):478-86. PubMed ID: 20149068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia.
    Luthringer R; Staner L; Noel N; Muzet M; Gassmann-Mayer C; Talluri K; Cleton A; Eerdekens M; Battisti WP; Palumbo JM
    Int Clin Psychopharmacol; 2007 Sep; 22(5):299-308. PubMed ID: 17690599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep latency and duration estimates among sleep disorder patients: variability as a function of sleep disorder diagnosis, sleep history, and psychological characteristics.
    Vanable PA; Aikens JE; Tadimeti L; Caruana-Montaldo B; Mendelson WB
    Sleep; 2000 Feb; 23(1):71-9. PubMed ID: 10678467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.
    Usall J; López-Carrilero R; Iniesta R; Roca M; Caballero M; Rodriguez-Jimenez R; Oliveira C; Bernardo M; Corripio I; Sindreu SD; González Piqueras JC; Felipe AE; Fernandez de Corres B; Ibáñez A; Huerta R;
    J Clin Psychiatry; 2014 Jun; 75(6):608-15. PubMed ID: 25004184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial.
    Hosseini SM; Farokhnia M; Rezaei F; Gougol A; Yekehtaz H; Iranpour N; Salehi B; Tabrizi M; Tajdini M; Ghaleiha A; Akhondzadeh S
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):846-55. PubMed ID: 24636461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?
    Tollefson GD; Andersen SW
    J Clin Psychiatry; 1999; 60 Suppl 5():23-9; discussion 30. PubMed ID: 10192404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.